Testicular neuroendocrine tumor in a 32‐year‐old man: A case report
Key Clinical Message A 32‐year‐old male with painful scrotal swelling who underwent radical orchiectomy and was diagnosed with a testicular neuroendocrine tumor. Determining whether testicular neuroendocrine tumor is primary or metastasis from another origin is crucial. Abstract Testicular neuroendo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-03-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.8620 |
| _version_ | 1797244327154417664 |
|---|---|
| author | Reza Dehghaniathar Asaad Moradi Nikoo Emtiazi |
| author_facet | Reza Dehghaniathar Asaad Moradi Nikoo Emtiazi |
| author_sort | Reza Dehghaniathar |
| collection | DOAJ |
| description | Key Clinical Message A 32‐year‐old male with painful scrotal swelling who underwent radical orchiectomy and was diagnosed with a testicular neuroendocrine tumor. Determining whether testicular neuroendocrine tumor is primary or metastasis from another origin is crucial. Abstract Testicular neuroendocrine tumors (TNET) are one of the rarest human neoplasms, with about 132 identified cases until 2015. Testicular neuroendocrine tumors are frequently manifest with painless scrotal swelling or mass. In this study, we present a 32‐year‐old male with a chief complaint of painful progressive swelling of the right testicle without any history of trauma. All laboratory tests were within the normal range. Ultrasound revealed two hyper‐vascular masses in the right testicle. Computed tomography was performed, and patients had no evidence of metastases. The patient underwent right radical orchiectomy, and a histopathological examination diagnosed the specimen with a well‐differentiated testicular neuroendocrine tumor. Because of the rarity of TNET, there are many controversial issues in the treatment, especially in cases with metastatic TNET. Determining whether testicular neuroendocrine tumor is primary or metastasis from another origin is crucial. Further studies are required to achieve optimum treatment for TNET. |
| first_indexed | 2024-04-24T19:09:15Z |
| format | Article |
| id | doaj.art-2b98cf74939747459d56dd7a5ad32098 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-04-24T19:09:15Z |
| publishDate | 2024-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-2b98cf74939747459d56dd7a5ad320982024-03-26T12:36:42ZengWileyClinical Case Reports2050-09042024-03-01123n/an/a10.1002/ccr3.8620Testicular neuroendocrine tumor in a 32‐year‐old man: A case reportReza Dehghaniathar0Asaad Moradi1Nikoo Emtiazi2Department of Urology, Firoozgar Hospital, School of Medicine Iran University of Medical Sciences Tehran IranDepartment of Urology, Firoozgar Hospital, School of Medicine Iran University of Medical Sciences Tehran IranDepartment of Pathology, Firoozgar Hospital, School of Medicine Iran University of Medical Sciences Tehran IranKey Clinical Message A 32‐year‐old male with painful scrotal swelling who underwent radical orchiectomy and was diagnosed with a testicular neuroendocrine tumor. Determining whether testicular neuroendocrine tumor is primary or metastasis from another origin is crucial. Abstract Testicular neuroendocrine tumors (TNET) are one of the rarest human neoplasms, with about 132 identified cases until 2015. Testicular neuroendocrine tumors are frequently manifest with painless scrotal swelling or mass. In this study, we present a 32‐year‐old male with a chief complaint of painful progressive swelling of the right testicle without any history of trauma. All laboratory tests were within the normal range. Ultrasound revealed two hyper‐vascular masses in the right testicle. Computed tomography was performed, and patients had no evidence of metastases. The patient underwent right radical orchiectomy, and a histopathological examination diagnosed the specimen with a well‐differentiated testicular neuroendocrine tumor. Because of the rarity of TNET, there are many controversial issues in the treatment, especially in cases with metastatic TNET. Determining whether testicular neuroendocrine tumor is primary or metastasis from another origin is crucial. Further studies are required to achieve optimum treatment for TNET.https://doi.org/10.1002/ccr3.8620carcinoid tumorneuroendocrine tumorstesticular cancertesticular neuroendocrine tumor |
| spellingShingle | Reza Dehghaniathar Asaad Moradi Nikoo Emtiazi Testicular neuroendocrine tumor in a 32‐year‐old man: A case report Clinical Case Reports carcinoid tumor neuroendocrine tumors testicular cancer testicular neuroendocrine tumor |
| title | Testicular neuroendocrine tumor in a 32‐year‐old man: A case report |
| title_full | Testicular neuroendocrine tumor in a 32‐year‐old man: A case report |
| title_fullStr | Testicular neuroendocrine tumor in a 32‐year‐old man: A case report |
| title_full_unstemmed | Testicular neuroendocrine tumor in a 32‐year‐old man: A case report |
| title_short | Testicular neuroendocrine tumor in a 32‐year‐old man: A case report |
| title_sort | testicular neuroendocrine tumor in a 32 year old man a case report |
| topic | carcinoid tumor neuroendocrine tumors testicular cancer testicular neuroendocrine tumor |
| url | https://doi.org/10.1002/ccr3.8620 |
| work_keys_str_mv | AT rezadehghaniathar testicularneuroendocrinetumorina32yearoldmanacasereport AT asaadmoradi testicularneuroendocrinetumorina32yearoldmanacasereport AT nikooemtiazi testicularneuroendocrinetumorina32yearoldmanacasereport |